ADCT ADC Therapeutics SA
$1.07▼ -3.60%
Healthcare
Other
After hours
$1.07▲ +0.00%
Sep 11, 5:31 PM ET
Volume 989.0K
Avg Volume (10D) 1.62M
Key Metrics & Fundamentals
Market Cap
$136.60M
P/E Ratio
–
Div Yield
–%
52W Range
0.78 - 4.98
% vs 50 MA
-8.39%
% vs 200 MA
-63.19%
RSI-14
42.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.33
Free Cash Flow
-$11.81M
Gross Rev
$19.25M
Gross Profit
$16.90M
EBITDA
-$14.63M
COGS
$2.35M
Operating Exp
$39.68M
Operating Income
-$22.78M
EBIT
-$22.78M
Pretax Income
-$16.57M
Net Income
-$16.57M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
PR Newswire · Sep 3, 2026 11:15 AM
ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
Insider Monkey · Aug 27, 2026 8:42 PM
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 7:49 PM
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook
Simply Wall St. · Aug 16, 2026 3:15 AM
ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says
MT Newswires · Aug 14, 2026 2:46 PM
ADC Therapeutics S.A. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:25 AM
ADC Therapeutics SA (ADCT) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles ...
GuruFocus.com · Aug 13, 2026 11:07 PM
ADC Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 8:04 PM
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 13, 2026 12:50 PM
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
PR Newswire · Aug 13, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADCT's money flow as a full page
Social Sentiment
No Reddit posts found for ADCT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.